SWOG clinical trial number
CTSU/A071701

GENOMICALLY-GUIDED TREATMENT TRIAL IN BRAIN METASTASES

Open
Phase
Abbreviated Title
GENOMICALLY-GUIDED TREATMENT IN BRAIN METASTASES
Status Notes
Step 0 & Step 1 Activation Effective 8/15/19; SWOG Activation Effective 9/1/19

Effective Tuesday, January 9, 2024, new patient registration (Step 1) to the entrectinib (NTRK/ROS1) cohort is closed.
Activated
09/01/2019
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS LISTED ON TITLE PAGE

Research committees

Early Therapeutics & Rare Cancers

Eligibility Criteria Expand/Collapse

Eligibility criteria are accessible from the protocol abstract page on the CTSU website (http://www.ctsu.org ).

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/AOST2032
SWOG Clinical Trial Number
CTSU/AOST2031